(GELS - GELTEQ LTD)

company profile

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Gelteq (GELS) is trading at 0.8061

Open Price
0.789
Previous close
0.8061
Previous close
0.8061
P/E Ratio
0
Sector
Health Care
Shares outstanding
10711059
Primary exchange
NASDAQ-NMS
ISIN
AU0000218109